1 Glorious Growth Stock Down 78% to Buy Hand Over Fist Before 2026

Core Insights - Docusign's stock experienced significant growth during the COVID-19 pandemic, reaching a peak of $310 in September 2021, but has since declined by 78% to $67 as demand normalized in 2022 [1][2] Group 1: Company Performance - The introduction of the Intelligent Agreement Management (IAM) platform aims to simplify agreement management processes and is helping Docusign regain some momentum [3] - Docusign's stock has fallen significantly due to the slowdown in demand for its products post-pandemic [9] Group 2: Market Opportunity - The IAM platform addresses a $2 trillion issue in the business community related to inefficient agreement management processes, referred to as the "agreement trap" [5] - The Navigator feature within IAM allows businesses to store and search digital documents efficiently, significantly reducing the time employees spend on manual searches [6] Group 3: Product Features - Navigator has seen a 150% increase in the number of documents processed in the fiscal 2026 second quarter compared to six months prior [7] - Other IAM features include AI-Assisted Review, which identifies risks and opportunities in contracts, and Maestro, which enables the creation of agreement workflows without coding [8]